Elanco Animal Health (ELAN) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Total Assets Chart for Elanco Animal Health
Elanco Animal Health (ELAN) total assets for FY2025 were USD 13.4B, a 5.9% change from FY2024. Elanco Animal Health's total assets grew from USD 8.1B in 2016 to USD 13.4B in 2025 (64.9% over 9 years). Total assets compound annual growth rate: 5-year CAGR of -5.5%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $11.17B
- Implied Share Price
- $22.36
- Enterprise Value
- $14.66B
- Revenue (TTM)
- $5.02B
- EBITDA
- $1.01B
- Profit Margin
- -3.96%
- Trailing P/E
- —
- Forward P/E
- 17.36
- Price/Book (MRQ)
- 1.71
- Price/Sales (TTM)
- 2.23
- EV/EBITDA
- 18.92
- EV/Revenue
- 2.92
- Dividend Yield
- —
- Book Value
- $13.19
- Free Cash Flow (FY2025)
- $284.00M
- Free Cash Flow Yield
- 2.54%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.